Clinical Anesthesia Procedures
Cangrelor
General
Antiplatelet agent. It is a direct P2Y12 platelet-receptor inhibitor that blocks adenosine diphosphate (ADP)–induced platelet activation and aggregation.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Pino, Richard M., editor. "Cangrelor." Clinical Anesthesia Procedures, 10th ed., Wolters Kluwer, 2022. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728480/all/Cangrelor.
Cangrelor. In: Pino RMR, ed. Clinical Anesthesia Procedures. Wolters Kluwer; 2022. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728480/all/Cangrelor. Accessed July 20, 2025.
Cangrelor. (2022). In Pino, R. M. (Ed.), Clinical Anesthesia Procedures (10th ed.). Wolters Kluwer. https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728480/all/Cangrelor
Cangrelor [Internet]. In: Pino RMR, editors. Clinical Anesthesia Procedures. Wolters Kluwer; 2022. [cited 2025 July 20]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728480/all/Cangrelor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cangrelor
ID - 728480
ED - Pino,Richard M,
BT - Clinical Anesthesia Procedures
UR - https://anesth.unboundmedicine.com/anesthesia/view/ClinicalAnesthesiaProcedures/728480/all/Cangrelor
PB - Wolters Kluwer
ET - 10
DB - Anesthesia Central
DP - Unbound Medicine
ER -
